Annual Shareholders Equity
$395.74 M
+$2.67 M+0.68%
December 31, 2024
Summary
- As of March 13, 2025, CTKB annual stockholders equity is $395.74 million, with the most recent change of +$2.67 million (+0.68%) on December 31, 2024.
- During the last 3 years, CTKB annual shareholders equity has fallen by -$9.30 million (-2.30%).
- CTKB annual shareholders equity is now -6.95% below its all-time high of $425.30 million, reached on December 31, 2022.
Performance
CTKB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$395.74 M
+$10.27 M+2.67%
December 31, 2024
Summary
- As of March 13, 2025, CTKB quarterly stockholders equity is $395.74 million, with the most recent change of +$10.27 million (+2.67%) on December 31, 2024.
- Over the past year, CTKB quarterly shareholders equity has increased by +$2.67 million (+0.68%).
- CTKB quarterly shareholders equity is now -6.95% below its all-time high of $425.30 million, reached on December 31, 2022.
Performance
CTKB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTKB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.7% | +0.7% |
| 3 y3 years | -2.3% | -6.7% |
| 5 y5 years | +1049.0% | -6.7% |
CTKB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | +0.7% | -7.0% | +2.7% |
| 5 y | 5-year | -7.0% | +1049.0% | -7.0% | +2569.0% |
| alltime | all time | -7.0% | +1049.0% | -7.0% | +2569.0% |
Cytek Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $395.74 M(+0.7%) | $395.74 M(+2.7%) |
| Sep 2024 | - | $385.46 M(-0.9%) |
| Jun 2024 | - | $389.12 M(-0.9%) |
| Mar 2024 | - | $392.61 M(-0.1%) |
| Dec 2023 | $393.06 M(-7.6%) | $393.06 M(-5.4%) |
| Sep 2023 | - | $415.52 M(-2.0%) |
| Jun 2023 | - | $424.18 M(+0.2%) |
| Mar 2023 | - | $423.46 M(-0.4%) |
| Dec 2022 | $425.30 M | $425.30 M(+2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $416.45 M(+1.3%) |
| Jun 2022 | - | $411.03 M(+0.9%) |
| Mar 2022 | - | $407.24 M(+0.5%) |
| Dec 2021 | $405.04 M(-2627.1%) | $405.04 M(+0.5%) |
| Sep 2021 | - | $402.88 M(-3665.3%) |
| Jun 2021 | - | -$11.30 M(-25.0%) |
| Mar 2021 | - | -$15.07 M(-6.0%) |
| Dec 2020 | -$16.03 M(-61.6%) | -$16.03 M |
| Dec 2019 | -$41.70 M | - |
FAQ
- What is Cytek Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Cytek Biosciences?
- What is Cytek Biosciences annual shareholders equity year-on-year change?
- What is Cytek Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cytek Biosciences?
- What is Cytek Biosciences quarterly shareholders equity year-on-year change?
What is Cytek Biosciences annual stockholders equity?
The current annual shareholders equity of CTKB is $395.74 M
What is the all time high annual shareholders equity for Cytek Biosciences?
Cytek Biosciences all-time high annual stockholders equity is $425.30 M
What is Cytek Biosciences annual shareholders equity year-on-year change?
Over the past year, CTKB annual stockholders equity has changed by +$2.67 M (+0.68%)
What is Cytek Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of CTKB is $395.74 M
What is the all time high quarterly shareholders equity for Cytek Biosciences?
Cytek Biosciences all-time high quarterly stockholders equity is $425.30 M
What is Cytek Biosciences quarterly shareholders equity year-on-year change?
Over the past year, CTKB quarterly stockholders equity has changed by +$2.67 M (+0.68%)